Furthermore, increased plasma levels of MIF were identified as a risk factor for increased heart failure in CHD patients with impaired glucose tolerance or type 2 diabetes mellitus (Makino et al., 2010), and were associated with inflammatory marker expression in patients with acute coronary syndrome (ACS) (Muller et al., 2012). Here, MIF is linked to diabetes mellitus.